Neuro-Oncology Reviews
Volume
24 Number 24
31 December 2022
Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 24, 31 December
Kunikowska J, Morgenstern A, Pełka
K, Bruchertseifer F, Królicki L.
Targeted
alpha therapy for glioblastoma.
Front
Med (Lausanne). 2022 Dec 16, 2022;9:1085245→.
doi: 10.3389/fmed.2022.1085245→.
PMID: 36590948→.
Review. ˍ
Mohanty C, Shandilya K, Deopujari
CE, Gupta G, Karmarkar V, Jaggi S.
Cervicomedullary
glioblastoma: A report of two cases with review of
literature.
Surg
Neurol Int. 2022 Dec 16;13:579→.
doi: 10.25259/SNI_581_2022→.
PMID: 36600754→.
Case report, Review. ˍ
Alkazemi
M, Lo YT, Hussein H, Mammi M, Saleh S, Araujo-Lama L, Mommsen S,
Pisano A, Lamba N, Bunevicius A, Mekary RA.
Laser
interstitial thermal therapy for the treatment of primary and
metastatic brain tumors: a systematic review and
meta-analysis.
World
Neurosurg. 2022 Dec 19:S1878-8750(22)01784-3→.
doi: 10.1016/j.wneu.2022.12.079→.
PMID: 36549438→.
Review, Meta-analysis˰ ˍ
Antonelli M, Poliani PL.
Adult type
diffuse gliomas in the new 2021 WHO Classification.
Pathologica.
2022 Dec 19;114(6):397-409. doi:
10.32074/1591-951X-823. PMID:
36534419. Review. ˍ
Barbareschi M, Gessi M, Giangaspero F.
Introduction.
Pathologica.
2022 Dec 19;114(6):395-396. doi:
10.32074/1591-951X-839. PMID:
36534418. Editorial. ˍ
Barresi V, Gianno F, Marucci G.
Newly
recognised Tumour Types in Glioneuronal tumours according to the
5th edition of the CNS WHO Classification.
Pathologica.
2022 Dec 19;114(6):447-454. doi:
10.32074/1591-951X-819. PMID:
36534423. Review. ˍ
Bertero L, Ricci AA, Tampieri C, Cassoni P, Modena P.
Ependymomas.
Pathologica.
2022 Dec 19;114(6):436-446. doi:
10.32074/1591-951X-817. PMID:
36534422. Review. ˍ
Fabbri VP, Caporalini C, Asioli S, Buccoliero A.
Paediatric-type
diffuse low-grade gliomas: a clinically and biologically distinct
group of tumours with a favourable outcome.
Pathologica.
2022 Dec 19;114(6):410-421. doi:
10.32074/1591-951X-828. PMID:
36534420. Review. ˍ
Gianno
F, Giovannoni I, Cafferata B, Diomedi-Camassei F, Minasi S,
Barresi S, Buttarelli FR, Alesi V, Cardoni A, Antonelli M,
Puggioni C, Colafati GS, Carai A, Vinci M, Mastronuzzi A, Miele E,
Alaggio R, Giangaspero F, Rossi S.
Paediatric-type
diffuse high-grade gliomas in the 5th CNS WHO Classification.
Pathologica.
2022 Dec 19;114(6):422-435. doi:
10.32074/1591-951X-830. PMID:
36534421. Review. ˍ
Mangesius
J, Mangesius S, Demetz M, Uprimny C, Di Santo G, Galijasevic M,
Minasch D, Gizewski ER, Ganswindt U, Virgolini I, Thomé C,
Freyschlag CF, Kerschbaumer J.
A
Multi-Disciplinary Approach to Diagnosis and Treatment of
Radionecrosis in Malignant Gliomas and Cerebral
Metastases.
Cancers
(Basel). 2022 Dec 19;14(24):6264→.
doi: 10.3390/cancers14246264→.
PMID: 36551750→.
Review. ˍ
Pizzimenti C, Gianno F, Gessi M.
Expanding
the spectrum of "mesenchymal" tumors of the central
nervous system.
Pathologica.
2022 Dec 19;114(6):455-464. doi:
10.32074/1591-951X-826. PMID:
36534424.
Review. ˍ
Estevez-Ordonez
D, Gary S, Atchley TJ, Maleknia P, George J, Laskay NMB, Gross E,
Devulapalli R, Johnston JM.
Immunotherapy
for Pediatric Brain and Spine Tumors, Current State and Future
Directions.
Pediatr
Neurosurg. 2022 Dec 22→.
doi: 10.1159/000528792→.
PMID: 36549282→.
Review. ˍ
Gianno
F, Giovannoni I, Cafferata B, Diomedi-Camassei F, Minasi S,
Barresi S, Buttarelli FR, Alesi V, Cardoni A, Antonelli M,
Puggioni C, Colafati GS, Carai A, Vinci M, Mastronuzzi A, Miele E,
Alaggio R, Giangaspero F, Rossi S.
Paediatric-type
diffuse high-grade gliomas in the 5th CNS WHO
Classification.
Pathologica.
2022 Dec 19;114(6):422-435→.
doi: 10.32074/1591-951X-830→.
PMID: 36534421→.
Review.
ˍ
Yoo
W, Kim S, Garcia M, Mehta S, Sanai N.
Evaluation
of two-stage
designs of
Phase 2 single-arm trials in glioblastoma: a systematic
review.
BMC
Med Res Methodol. 2022 Dec 22;22(1):327→.
doi: 10.1186/s12874-022-01810-7→.
PMID: 36550391→.
Review. ˍ
Brar HK, Jose
J, Wu Z, Sharma M.
Tyrosine
Kinase Inhibitors for Glioblastoma Multiforme: Challenges and
Opportunities for Drug Delivery.
Pharmaceutics.
2022 Dec 24;15(1):59→.
doi: 10.3390/pharmaceutics15010059→.
PMID: 36678688→.
Review.
ˍ
Manoharan
N, Liu KX, Mueller S, Haas-Kogan DA, Bandopadhayay P.
Pediatric
low-grade glioma: Targeted therapeutics and clinical trials in the
molecular era.
Neoplasia.
2022 Dec 24, 2023;36:100857→.
doi: 10.1016/j.neo.2022.100857→.
PMID: 36566593→.
Review.
ˍ
Kulubya ES,
Kercher MJ, Phillips HW, Antony R, Edwards MSB.
Advances
in the Treatment of Pediatric Brain Tumors.
Children
(Basel). 2022 Dec 27;10(1):62→.
doi: 10.3390/children10010062→.
PMID: 36670613→.
Review.
ˍ
Muthukumar S, Darden J, Crowley J,
Witcher M, Kiser J.
A
Comparison of PET Tracers in Recurrent High-Grade Gliomas: A
Systematic Review.
Int
J Mol Sci. 2022 Dec 27, 2023;24(1):408→.
doi: 10.3390/ijms24010408→.
PMID: 36613852→.
Review. ˍ
Di
Nunno V, Franceschi E, Gatto L, Tosoni A, Bartolini S, Brandes
AA.
How
to treat histone 3 altered gliomas: molecular landscape and
therapeutic developments.
Expert
Rev Clin Pharmacol. 2022 Dec 28:1-10→.
doi: 10.1080/17512433.2023.2163385→.
PMID: 36576307→.
Review˰ ˍ
Raghu ALB, Chen JA, Valdes PA,
Essayed W, Claus E, Arnaout O, Smith TR, Chiocca EA, Peruzzi PP,
Bernstock JD.
Cerebellar
High-Grade Glioma: A Translationally Oriented Review of the
Literature.
Cancers
(Basel). 2022 Dec 28, 2023;15(1):174→.
doi: 10.3390/cancers15010174→.
PMID: 36612169→.
Review. ˍ
Shalita C,
Hanzlik E, Kaplan S, Thompson EM.
Immunotherapy
for the treatment of pediatric brain tumors: a narrative
review.
Transl
Pediatr. 2022 Dec 28;11(12):2040-2056→.
doi: 10.21037/tp-22-86→.
PMID: 36643672→.
Review.
ˍ
Somma
T, Bove I, Vitulli F, Cappabianca P, Pessina F, Alviggi C, Santi
L, Della Pepa GM, Sabatino G, Olivi A, Ius T; Neuro-Oncology
committee of the SINch (Società Italiana di
Neurochirurgia).
Management
and treatment of brain tumors during pregnancy: an Italian
survey.
J
Neurooncol. 2022 Dec 29→.
doi: 10.1007/s11060-022-04215-0→.
PMID: 36580221→.
Review˰ ˍ
Wang
J, Xiang C, Cai Y, Mei Z, Lu Q, Liu B, Zou L.
Clinicopathological
and prognostic significance of COX-2 in glioma patients: a
meta-analysis.
Arq
Neuropsiquiatr. 2022 Dec 29;80(12):1254-1261→.
doi: 10.1055/s-0042-1758864→.
PMID: 36580964→.
Meta-analysis. ˍ
Zhu
Y, Teng Y, Xu S, Xu Y, Zhu B, Yan W, Liu J.
Eczema
as a protective factor for brain cancer: a meta-analysis.
BMC
Cancer. 2022 Dec 29;22(1):1360→.
doi: 10.1186/s12885-022-10471-0→.
PMID: 36581832→.
Meta-analysis. ˍ
Chen K, Andrade-Barazarte H, Liang
W, Zhu Q, Guo H, Li Y, Li H, Qian R.
Post-traumatic
brain injury glioma: Characteristics, report of 2 cases report and
literature review.
Medicine
(Baltimore). 2022 Dec 30, 2022;101(52):e32477→.
doi: 10.1097/MD.0000000000032477→.
PMID: 36596004→.
Case report, Review. ˍ
Panagopoulos
D, Stranjalis G, Gavra M, Boviatsis E, Korfias S, Karydakis P,
Themistocleous M.
The
Entity of Cerebellar Mutism Syndrome: A Narrative Review Centered
on the Etiology, Diagnostics, Prevention, and Therapeutic
Options.
Children
(Basel). 2022 Dec 30;10(1):83→.
doi: 10.3390/children10010083→.
PMID: 36670634→.
Review.
ˍ
Fan
Y, Wang T, Lei J, Fei F, Liu J, Liu Y.
Effects
of postoperative radiotherapy and docetaxel and PD-1 inhibitors on
the survival and safety of glioblastoma patients: a systematic
review and meta-analysis.
Ann
Transl Med. 2022 Dec 31;10(24):1326→.
doi: 10.21037/atm-22-2670→.
PMID: 36660707→.
Review, Meta-analysis. ˍ
Goff KM, Zheng C, Alonso-Basanta
M.
Proton
radiotherapy for glioma and glioblastoma.
Chin
Clin Oncol. 2022 Dec 31;11(6):46→.
doi: 10.21037/cco-22-92→.
PMID: 36632979→.
Review. ˍ